Lantern Pharma to Report Third Quarter 2023 Operating & Financial Results on November 8th, 2023 at 4:30 p.m. ET
DALLAS--(BUSINESS WIRE)--Nov 1, 2023--Lantern Pharma Inc. (NASDAQ: <a ...
DALLAS--(BUSINESS WIRE)--Nov 1, 2023--Lantern Pharma Inc. (NASDAQ: <a ...
BOTHELL, Wash.--(BUSINESS WIRE)--Nov 1, 2023--Seagen Inc. (Nasdaq:SGEN) (Seagen or the Company) reported financial results today for the third quarter ended September 30, 2023.David Epstein, Chief Executive Officer of Seagen said, 鈥淪eagen continues to build momentum in 2023 and delivered ...
TORONTO--(BUSINESS WIRE)--Nov 1, 2023--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to develop next-generation therapies targeting pain and inflammation, is pleased to announce the completion of the ...
LONDON & NEW YORK--(BUSINESS WIRE)--Nov 1, 2023--ViroCell Biologics (鈥淰iroCell鈥� or the 鈥淐ompany鈥�), a specialist contract development and manufacturing organisation (鈥淐DMO鈥�) for cell and gene therapy (CGT) clinical trials, announces that the Company is now able to ...
<ul><li>FDA-compliant manufacture of intravenous Ketamine is a required component of a New Drug Application</li><li>Intravenous Ketamine has become widely used for treating depression and suicidality but has never been presented to FDA for ...
SAN FRANCISCO--(BUSINESS WIRE)--Oct 30, 2023--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Jennifer Towne, Ph.D., as Executive Vice President and Chief Scientific Officer, effective November 6, 2023. Dr. Towne will be responsible for leading the Company蘑菇视频 research ...
